Content about pain management

April 24, 2014

As part of the launch of DSN’s new microsite, DrugStoreNews.com/Pain-Management, DSN had the opportunity to speak with Carmen Catizone, executive director of the National Association of Boards of Pharmacy, regarding a new initiative that the association is spearheading to address the current patient access problem when it comes to pain management pharmaceuticals.

Audio Q&A: As part of the launch of DSN’s new microsite, DrugStoreNews.com/Pain-Management, DSN had the opportunity to speak with Carmen Catizone, executive director of the National Association of Boards of Pharmacy, regarding a new initiative that the association is spearheading to address the current patient access problem when it comes to pain management pharmaceuticals. 

April 21, 2014

ABC News will be hosting a live twitter chat focusing on pain management on Tuesday, April 22, at 1 p.m., as part of the news agency's next ABC News National Tweet Chat.

NEW YORK — ABC News will be hosting a live Twitter chat focusing on pain management on Tuesday, April 22, at 1 p.m., as part of the news agency's next ABC News National Tweet Chat. ABC plans to cover a range of topics related to pain management, including chronic pain and palliative care.

To join in on the conversation, click here

March 25, 2014

The Drug Store News Group, the leading provider of news, information and clinical education for the retail pharmacy industry, has launched the new microsite, Drugstorenews.com/pain-management, to help bring attention to another tragic side of the prescription drug abuse story — the millions of Americans who live in chronic pain that may be unable to access the medications they need thanks to proposed changes in regulatory policy.

NEW YORK — The Drug Store News Group, the leading provider of news, information and clinical education for the retail pharmacy industry, has launched the new microsite, Drugstorenews.com/pain-management, to help bring attention to another tragic side of the prescription drug abuse story — the millions of Americans who live in chronic pain that may be unable to access the medications they need thanks to proposed changes in regulatory policy.

March 11, 2014

A survey by the National Pain Foundation of more than 300 people who live with chronic pain is shedding light on how chronic pain sufferers are treated by their healthcare providers.

GOLDEN, Colo. — A survey by the National Pain Foundation of more than 300 people who live with chronic pain is shedding light on how chronic pain sufferers are treated by their healthcare providers.  

The findings revealed that pain patients are uncomfortable when visiting their pharmacy. Fifty-two percent said they "are concerned that they will be treated like a drug addict by their pharmacist," with 29% expressing concern that they would "be embarrassed by their pharmacist."

February 25, 2014

New research released Tuesday found that when it comes to treating pain, a growing number of consumers know how to safely use medicines with acetaminophen and to avoid accidental overdose and liver damage.

WASHINGTON — New research released Tuesday found that when it comes to treating pain, a growing number of consumers know how to safely use medicines with acetaminophen and to avoid accidental overdose and liver damage. A nationwide consumer survey conducted by the Consumer Healthcare Products Association Educational Foundation, in conjunction with its work on the Acetaminophen Awareness Coalition’s Know Your Dose educational campaign, shows that consumer safe use knowledge and risk awareness has increased over a three year period (2010-2013).

January 29, 2014

Omron Healthcare on Tuesday announced the release of its new Pain Relief Pro electroTHERAPY unit.

LAKE FOREST, Ill. — Omron Healthcare on Tuesday announced the release of its new Pain Relief Pro electroTHERAPY unit. Its versatility delivers more settings and more power for more relief with 10 power levels and eight pre-set modes.

December 11, 2013

First Aid Shot Therapy on Wednesday announced the launch of its F.A.S.T. Pain Relief product, a berry-flavored, single-dose, liquid relief shot.

SEATTLE — First Aid Shot Therapy on Wednesday announced the launch of its F.A.S.T. Pain Relief product, a berry-flavored, single-dose, liquid relief shot. According to the company, F.A.S.T.'s active ingredient choline salicylate may enter a person's blood stream up to five times faster than aspirin. 

December 9, 2013

BioElectronics on Monday announced that Boots will be selling its ActiPatch Pain Therapy products in select stores for back, knee and musculoskeletal ailments.

FREDERICK, Md. — BioElectronics on Monday announced that Boots will be selling its ActiPatch Pain Therapy products in select stores for back, knee and musculoskeletal ailments.  

The ActiPatch provides pain management therapy for common musculoskeletal complaints through duration pulsed electromagnetic therapy in a small device designed for personal extended use.

November 21, 2013

Vireo Systems on Thursday launched CanineActiv, a pain reliever for dogs that will serve as an alternative to NSAIDs.

MADISON, Tenn. — Vireo Systems on Thursday launched CanineActiv, a pain reliever for dogs that will serve as an alternative to NSAIDs. "We have had outstanding success with NSAID alternatives for people, and we knew that many of our discoveries and innovations could be extended to dogs," Mark Faulkner, Vireo Systems president said. "With CanineActiv, consumers can expect the same level of safe and effective pain relief for their dogs as they've come to expect for themselves from AminoActiv."

October 28, 2013

Depomed has launched a new drug for breakthrough pain in cancer patients, the company said Monday.

NEWARK, Calif. — Depomed has launched a new drug for breakthrough pain in cancer patients, the company said Monday.

The drug maker announced the launch of Lazanda (fentanyl) nasal spray, meant for treating adults who are taking opioid painkillers, but have become tolerant to them. The company also have launched a Signature Support Program designed to streamline patient access to the drug, including reimbursement and co-pay assistance. Other benefits of the program include prescription reminders and eligibility for one month's supply for free.

October 3, 2013

A patient may be able to eat all of the ice cream he wants after having his tonsils removed, but researchers at Henry Ford Hospital in Detroit say he doesn't necessarily need a prescription to reduce post-operative pain — an over-the-counter pain reliever is just as effective.

DETROIT — A patient may be able to eat all of the ice cream he wants after having his tonsils removed, but researchers at Henry Ford Hospital in Detroit say he doesn't necessarily need a prescription to reduce post-operative pain — an over-the-counter pain reliever is just as effective.

The study released Monday found over-the-counter ibuprofen manages pain after a tonsillectomy for children and adults, as well as the prescription pain medications acetaminophen with hydrocodone and acetaminophen with codeine, which is no longer recommended for use in children.

September 13, 2013

Companies that make long-acting opioid painkillers will be required to conduct studies to assess their safety, while use of the drugs will be restricted, under new requirements from the Food and Drug Administration.

SILVER SPRING, Md. — Companies that make long-acting opioid painkillers will be required to conduct studies to assess their safety, while use of the drugs will be restricted, under new requirements from the Food and Drug Administration.

The agency announced new labeling changes and regulatory requirements for makers of extended-release and long-acting opioids, citing the risk the drugs carry of overdose, abuse and withdrawal. In response, a group also cautioned consumers to be careful when using non-steroidal anti-inflammatory drugs.

September 10, 2013

Pfizer Consumer recently launched its Advil Film Coated tablets, and the first-to-market formulation marks the debut of Advil Ion Core Technology in the United States.

MADISON, N.J. — Pfizer Consumer recently launched its Advil Film Coated tablets, and the first-to-market formulation marks the debut of Advil Ion Core Technology in the United States. This fast-dissolving technology along with a unique, specially formulated ultra-thin coating, is engineered for speed, going to work in minutes.

September 3, 2013

HoMedics on Tuesday announced the launch of its Rapid Relief Electronic Pain Relief Pad, a wireless, portable Transcutaneous Electrical Nerve Stimulation (TENS) device to be sold over the counter.

COMMERCE TOWNSHIP, Mich. — HoMedics on Tuesday announced the launch of its Rapid Relief Electronic Pain Relief Pad, a wireless, portable Transcutaneous Electrical Nerve Stimulation (TENS) device to be sold over the counter. The device is designed to instantly block the nerve pathway from transmitting pain signals from sore and aching muscles. 

July 30, 2013

Hisamitsu America, the manufacturer of Salonpas, an OTC pain patch that is FDA approved and clinically proven, announced the launch of Salonpas Deep Relieving Gel, a topical analgesic solution.

FLORHAM PARK, N.J. — Hisamitsu America, a division of Hisamitsu Pharmaceutical Co. Inc. and the manufacturers of Salonpas, an OTC pain patch that is FDA approved and clinically proven, last week announced the launch of Salonpas Deep Relieving Gel, a topical analgesic solution.

July 18, 2013

According to the Administration on Aging, the United States is similar to many other countries in the developed world — and even a few in the developing world — in that the population is getting older.

According to the Administration on Aging, the United States is similar to many other countries in the developed world — and even a few in the developing world — in that the population is getting older. According to the AOA, people in the United States ages 65 years and older numbered 39.6 million in 2009, a number expected to reach 72.1 million by 2030. In 2000, the elderly represented 12.4% of the population in the United States, but will constitute 19% of it in 17 years.

June 10, 2013

Prestige Brands on Monday announced the launch of Goody's Headache Relief Shot. The product combines the pain relievers acetaminophen and caffeine in a fast-acting, single-dose liquid.

TARRYTOWN, N.Y. — Prestige Brands on Monday announced the launch of Goody's Headache Relief Shot. The product combines the pain relievers acetaminophen and caffeine in a fast-acting, single-dose liquid. 

March 26, 2013

The National Community Pharmacists Association called for the rejection of a proposal made by Sens. Joe Manchin, D-W.Va., and Mark Kirk, R.-Ill., to reschedule Vicodin and other hydrocodone-containing products from Schedule III to Schedule II of the Controlled Substances Act.

ALEXANDRIA, Va. — The National Community Pharmacists Association last week called for the rejection of a proposal made by Sens. Joe Manchin, D-W.Va., and Mark Kirk, R.-Ill., to reschedule Vicodin and other hydrocodone-containing products from Schedule III to Schedule II of the Controlled Substances Act.

March 8, 2013

Omron recently charged analgesic aisles with a new pain relief option.

LAKE FOREST, Ill. — Omron recently charged analgesic aisles with a new pain relief option. Omron's Electro-Therapy Pain Relief unit is the only approved transcutaneous electrical nerve stimulation unit on the market and should be an adjunctive sale for chronic pain sufferers. The product could add a spark to nonmedicinal, external pain relief. Sales of heat and ice packs were relatively flat in 2012, with sales approaching $235 million.

March 4, 2013

The Food and Drug Administration has accepted a regulatory application for a new painkiller from Iroko Pharmaceuticals, the drug maker said.

PHILADELPHIA — The Food and Drug Administration has accepted a regulatory application for a new painkiller from Iroko Pharmaceuticals, the drug maker said Monday.

Iroko is seeking approval for a lower-dose, submicron diclofenac, a non-steroidal anti-inflammatory drug for treating mild to moderate acute pain in adults.

February 28, 2013

Homeopathic analgesic manufacturer Vireo Systems released a study finding that seniors over the age of 75 were six times more likely to suffer side effects associated with non-steroidal anti-inflammatory drugs.

MADISON, Tenn. — Homeopathic analgesic manufacturer Vireo Systems on Thursday released a study finding that seniors over the age of 75 were six times more likely to suffer side effects associated with non-steroidal anti-inflammatory drugs. 

According to the study, nearly 33 million people, including 13.8 million seniors over the age of 65, regularly use NSAIDs for treating pain and inflammation. Gastrointestinal issues, renal problems and cardiac complications are the top-three most-cited side effects.

February 1, 2013

Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

OAKLAND, Calif. — Men taking long-acting medications for chronic pain are almost five times more likely to have low testosterone levels, according to a new study by Kaiser Permanente.

The study, which the healthcare system called the first to show a significant difference in risk between short-acting and long-acting opioids, appeared in The Clinical Journal of Pain.

January 23, 2013

A new study indicated that some parents may not be sufficiently concerned about misuse of narcotic painkillers by children and teenagers.

ANN ARBOR, Mich. — A new study indicated that some parents may not be sufficiently concerned about misuse of narcotic painkillers by children and teenagers.

January 7, 2013

Topical pain relievers may be better suited for joint pain, according to a report published in the January 2013 issue of the Harvard Men's Health Watch.

BOSTON — Topical pain relievers may be better suited for joint pain, according to a report published in the January 2013 issue of the Harvard Men's Health Watch

"Topical pain relievers can be very helpful for the more superficial joints like the knees, ankles, feet, elbows and hands," stated Rosalyn Nguyen, a clinical instructor in physical medicine and rehabilitation at Harvard Medical School. "In those areas, the medication can penetrate closer to the joint."

December 19, 2012

Nutra Pharma will introduce a stronger version of its OTC pain reliever, the company said Wednesday.

CORAL SPRINGS, Fla. — Nutra Pharma will introduce a stronger version of its OTC pain reliever, the company said Wednesday.

Nutra Pharma — which is developing treatments for such diseases as HIV, multiple sclerosis and adrenomyeloneuropathy — announced the planned introduction of Nyloxin Military Strength in order to combat opiate abuse and overuse of NSAIDs by military personnel.